Tevogen Inc.
TVGN· Nasdaq
TVGNTevogen Inc.
Filed May 22, 2023 · 10-Q · 52 days after period end · 0001410578-23-001349
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Net Income | -$30.76M | -$25.99K |
| EPS Diluted | -$0.26 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tevogen Inc. · CIK 1860871 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 22, 2023 · 52 d after period end
